4//SEC Filing
Carver Kyle 4
Accession 0001757072-25-000008
CIK 0002044725other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:16 PM ET
Size
6.9 KB
Accession
0001757072-25-000008
Insider Transaction Report
Form 4
Evommune, Inc.EVMN
Carver Kyle
Chief Financial Officer
Transactions
- Conversion
Common Stock
2025-11-07+3,175→ 75,800 total - Conversion
Series B Preferred Stock
2025-11-07−25,000→ 0 total→ Common Stock (3,175 underlying)
Footnotes (1)
- [F1]Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date.
Documents
Issuer
Evommune, Inc.
CIK 0002044725
Entity typeother
Related Parties
1- filerCIK 0001757072
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:16 PM ET
- Size
- 6.9 KB